CHECKMATE PHARMACEUTICALS IN - COM (CMPI)

CUSIP: 162818108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
16,172,706
Share change
-127,227
Total reported value
$235,874,000
Price per share
$14.59
Number of holders
36
Value change
-$1,573,899
Number of buys
16
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 162818108?
CUSIP 162818108 identifies CMPI - CHECKMATE PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHECKMATE PHARMACEUTICALS IN - COM (CMPI) as of Q4 2020

As of 31 Dec 2020, CHECKMATE PHARMACEUTICALS IN - COM (CMPI) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,172,706 shares. The largest 10 holders included venBio Partners LLC, Sofinnova Investments, Inc., Novo Holdings A/S, Medicxi Ventures Management (Jersey) Ltd, Omega Fund Management, LLC, Clough Capital Partners L P, FMR LLC, Sectoral Asset Management Inc, BlackRock Inc., and DEUTSCHE BANK AG\. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.